Development of NGS-Based Workflows for CQAs for Product Characterization in CGT:  Biosafety and Genome Integrity

In this webinar, Andrew Hillhouse, Principal Scientist at Fujifilm Biotechnologies, presents how NGS–based workflows are developed to support characterization of critical quality attributes in cell and gene therapy. You will gain insight into applying NGS across identity, genome integrity, and biosafety testing, with a focus on modular, end‑to‑end workflow design and how standardized analysis pipelines and automated Playbooks enable scalable data interpretation and support long‑term readiness for validation.

This talk is part of Genedata’s Open Forum series on NGS-based workflows for biopharmaceutical R&D and manufacturing.